Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan.
Fouassier, Laura
Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. [electronic resource] - Journal of hepatology Aug 2002 - 184-91 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0168-8278
10.1016/s0168-8278(02)00107-1 doi
Animals
Antihypertensive Agents--pharmacology
Bile Acids and Salts--metabolism
Bile Canaliculi--drug effects
Bilirubin--metabolism
Bosentan
Cholesterol--metabolism
Endothelin Receptor Antagonists
Male
Membrane Transport Proteins
Multidrug Resistance-Associated Protein 2
Multidrug Resistance-Associated Proteins--metabolism
Phospholipids--metabolism
Rats
Rats, Mutant Strains
Rats, Sprague-Dawley
Rats, Wistar
Receptor, Endothelin A
Receptor, Endothelin B
Sulfonamides--pharmacology
Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. [electronic resource] - Journal of hepatology Aug 2002 - 184-91 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0168-8278
10.1016/s0168-8278(02)00107-1 doi
Animals
Antihypertensive Agents--pharmacology
Bile Acids and Salts--metabolism
Bile Canaliculi--drug effects
Bilirubin--metabolism
Bosentan
Cholesterol--metabolism
Endothelin Receptor Antagonists
Male
Membrane Transport Proteins
Multidrug Resistance-Associated Protein 2
Multidrug Resistance-Associated Proteins--metabolism
Phospholipids--metabolism
Rats
Rats, Mutant Strains
Rats, Sprague-Dawley
Rats, Wistar
Receptor, Endothelin A
Receptor, Endothelin B
Sulfonamides--pharmacology